¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ŰƮ À¯Çüº°, ±â¼úº°, Å×½ºÆ® ¿Ï·á ÆÄ¶ó¹ÌÅͺ°, ¹Ì»ý¹°º°, ¸ñÀûº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® µ¿Çâ(2023-2030³â)
Biotechnology Reagents & Kits Market Size, Share & Trends Analysis Report By Kit Type (Detection Kits, Isolation Kits), By Technology, By Tested Parameters, By Micro-organisms, By Purpose, By End-use, By Region, And Segment Forecasts, 2023 - 2030
»óǰÄÚµå
:
1362908
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2023³â 09¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 200 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
»ý¸í °øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é ¼¼°è ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå ±Ô¸ð´Â 2023³âºÎÅÍ 2030³â±îÁö º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.9%·Î È®´ëµÇ¾úÀ¸¸ç 2030³â¿¡´Â 1Á¶ 3,772¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â Âü½ÅÇÏ°í ¼±ÁøÀûÀÎ Á¦Ç°ÀÇ µµÀÔ, »ý¸í°øÇÐ ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÇÕ¼º »ý¹°Çп¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.
»ý¸í°úÇÐ ¹× »ý¸í°øÇÐ ¿¬±¸¸¦ À§ÇÑ R&D ºñ¿ë Áõ°¡´Â ÇâÈÄ ¼ö³â°£ ½ÃÀåÀ» Å©°Ô °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áö³ ¼ö½Ê³âµ¿¾È »ý¸í °øÇÐ ºÎ¹®Àº »õ·Î¿î Ä¡·á¹ý ¹× ÀǾàǰ, »ý¹°ÇÐÀûÀ¸·Î Á¦¾î µÈ »ý»ê °øÁ¤, À¯ÀüÀÚ º¯Çü ½Äǰ, »ý¹°ÇÐÀû ±â¹Ý ÄÄÇ»ÆÃ ¹× ½Å¼ÒÀç·ÎÀÇ ÆÐ·¯´ÙÀÓ ÀüȯÀ» º¸¾Ò½À´Ï´Ù., ±×°ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
¾×Àû µðÁöÅÐ PCR, NGS, °Ô³ð ¿ÍÀÌµå ½ÃÄö½º µî Á¤È®µµ, ÀçÇö¼º, ŸÀÓ¶óÀο¡ ´ëÇÑ ºÐÀÚ Áø´Ü ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå¿¡¼ »ý¸í °øÇÐ ½Ã¾à ¹× ŰƮÀÇ Ã¤Åÿ¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±ä ¸®µå ½ÃÄö½ÌÀÇ ÃâÇöÀ¸·Î DNA1 ºÐÀÚ¸¦ Àд °Í¸¸À¸·Î ´õ ±ä DNA °¡´ÚÀÇ ½ÃÄö½ÌÀÌ °¡´ÉÇØ ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù.
¼¼Æ÷ ¹è¾ç ±â¼úÀº ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ¹æ´ëÇÑ Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼¼Æ÷ »ý¹°ÇÐ ¿¬±¸ÀÇ È®´ë·Î 2022³â¿¡ °¡Àå Å« ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. NGS ±â¼úÀ» ÀÌ¿ëÇÑ RNA-Seq´Â transcriptomeÀ» Á¶»çÇÏ´Â ¿¬±¸ Ä¿¹Â´ÏƼ°¡ ¼±ÅÃÇÏ´Â ±â¹ýÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º ºÐ¾ß´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á¿Í ¹é½Å ¿ä¹ý¿¡¼ÀÇ Ã¤¿ëÀÌ Áõ°¡ÇÏ¿© 2020³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÆÒµ¥¹Í(¼¼°èÀû À¯Çà)ÀÌ °è¼ÓµÇ°í ÀÖ´Â °ÍÀ¸·ÎºÎÅÍ, ¹ÙÀÌ·¯½º º¤Å͸¦ ÀÌ¿ëÇÑ ¹é½Å °³¹ß¿¡ ÁßÁ¡À» µÎ°í ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ Ç÷¯½ºÀÇ ¿µÇâÀ» ÁÖ°í ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â 2022³â¿¡ °¡Àå Å« ÆÇ¸Å Á¡À¯À²À» ¾ò¾úÀ¸¸ç ¹Ì±¹ÀÌ °¡Àå Å« °øÇå±¹ÀÌ µÇ¾ú½À´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç¿Í ¿¬±¸ Ȱµ¿¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÏ´Â °ÍÀºÀÌ Áö¿ªÀÇ ÃÖ´ë Á¡À¯À²¿¡ ±â¿©ÇÕ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶ó °³¼±, ´ë±â¾÷ »ý¸í°øÇÐ ±â¾÷ ÁøÀÔ, R&D Ȱµ¿ Áõ°¡·Î 2023³âºÎÅÍ 2030³â±îÁö °¡Àå ºü¸¥ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¹ÙÀÌ¿À ÀǾàǰ °³¹ß ±â¾÷°úÀÇ Á¦ÈÞ¸¦ ÅëÇØ Á¦Ç° °³¹ß ÇÁ·Î¼¼½º¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.
»ý¸í °øÇÐ ½Ã¾à ¹× ŰƮ ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
À¯Çà¿¡ ÀÇÇÑ ¼ö¿äÀÇ ³ôÀ̷κÎÅÍ 2022³âÀÇ ¸ÅÃâ Á¡À¯À²Àº °ËÃâ ŰƮ°¡ ÃÖ´ëÀÔ´Ï´Ù.
ÁõÆø ŰƮ´Â LAMP ±â¼ú°ú PCRÀÇ ¿ëµµ È®´ë·Î »ó´çÇÑ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) °Ë»çÀÇ °³¹ßÀº ÁÖ·Î ÇöÀå °Ë»ç ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
ÇöÀå DNA °Ë»ç´Â ¹ýÀÇÇÐ DNA °Ë»ç ¼ºñ½º¿Í Ãâ»ý Àü °Ë»ç ¿É¼ÇÀ» Æ÷ÇÔÇÑ DNA ºÎÀÚ °ü°è ¹× °¡Á· °ü°èÀÇ ±¤¹üÀ§ÇÑ ¼¿À» °ü¸®ÇÕ´Ï´Ù.
ÇöÀç ½ÃÀåÀÇ ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â °Ç° °ü¸® ºÐ¾ßÀÌ¸ç ½Ã¾à ¹× Å°Æ®ÀÇ º¸±Þ·üÀºÀÌ ºÐ¾ß¿¡¼ °¡Àå ³ô½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå »ý¸í°øÇÐ ½Ã¾à ¹× Ŷ ½ÃÀåÀÇ º¯¼ö µ¿Çâ ¹× ¹üÀ§
½ÃÀå °èÅë Àü¸Á
»óÀ§ ½ÃÀå Àü¸Á
°ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
º¸±Þ°ú ¼ºÀåÀÇ Àü¸Á ¸ÅÇÎ
½ÃÀå ¿ªÇÐ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå ºÐ¼® Åø
¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
PESTEL ºÐ¼®
Á¦4Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ: ŰƮ À¯ÇüÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â-2030³â)
Á¤Á¦ ŰƮ
Á¤Á¦ ŰƮ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
ÁõÆø ŰƮ
ÁõÆø ŰƮ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
°ËÃâ ŰƮ
°ËÃâ ŰƮ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
°Ý¸® ŰƮ
°Ý¸® ŰƮ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
±âŸ
±âŸ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
Á¦5Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ : ±â¼ú ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â ¹× 2030³â)
LAMP 񃬣
PCR
¼¼Æ÷ ±¸Á¶
½ÃÄö½º
Å©·Î¸¶Åä±×·¡ÇÇ
Àü±â¿µµ¿
ÇÃ·Î¿ì »çÀÌÅä¸ÞÆ®¸®
±âŸ ±â¼ú
Á¦6Àå »ý¸í°øÇÐ ½Ã¾à ¹× ŰƮ: Å×½ºÆ®µÈ ÆÄ¶ó¹ÌÅÍÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â ¹× 2030³â)
DNA
DNA ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
RNA
RNA ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
È¿¼Ò
È¿¼Ò ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
´Ü¹éÁú
´Ü¹éÁú ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
±âŸ
±âŸ ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
Á¦7Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ : ¹Ì»ý¹°ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â ¹× 2030³â)
¹ÚÅ׸®¾Æ
¹ÙÀÌ·¯½º
±Õ·ù
±â»ýÃæ
Á¦8Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ:¸ñÀûÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â ¹× 2030³â)
ÇöÁö
ÇöÁö ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
¿¬±¸½Ç
¿¬±¸½Ç ½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
Á¦9Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ: ÃÖÁ¾ ¿ëµµ ÃßÁ¤ ¹× µ¿Ç⠺м®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× Ŷ ½ÃÀå : µ¿Çâ ¹× ½ÃÀå Á¡À¯À² ºÐ¼®(2022³â ¹× 2030³â)
ÇコÄɾî
½Ä·®°ú ³ó¾÷
õ¿¬ÀÚ¿ø°ú ȯ°æ
Á¦10Àå ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå :Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®
Áö¿ªº° Àü¸Á
Áö¿ªº° ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ½Ã¾à ¹× ŰƮ ½ÃÀå : Áß¿äÇÑ Æ÷ÀÎÆ®
ºÏ¹Ì
½ÃÀå Ãß°è ¹× ¿¹Ãø(2018³â-2030³â)
¹Ì±¹
ij³ª´Ù
À¯·´
¿µ±¹
µ¶ÀÏ
ÇÁ¶û½º
ÀÌÅ»¸®¾Æ
½ºÆäÀÎ
µ§¸¶Å©
½º¿þµ§
³ë¸£¿þÀÌ
¾Æ½Ã¾ÆÅÂÆò¾ç
ÀϺ»
Áß±¹
Àεµ
È£ÁÖ
ű¹
Çѱ¹
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
³²¾ÆÇÁ¸®Ä«
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
Äí¿þÀÌÆ®
Á¦11Àå °æÀï ±¸µµ
ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
½ÃÀå ÁøÃâ±â¾÷ÀÇ ºÐ·ù
Thermos Fisher Scientific
QIAGEN
New England Biolabs
Illumina, Inc.
Agilent Technologies, Inc.
Bio Rad Laboratories
F. Hoffman-La Roche Ltd.
Merck KGaA
Promega Corp.
Takara Bio, Inc.
LGC Ltd.
Toyobo Co. Ltd
BJH
¿µ¹® ¸ñÂ÷
Biotechnology Reagents & Kits Market Growth & Trends:
The global biotechnology reagents & kits market size is expected to reach USD 1,377.2 billion by 2030, expanding at a CAGR of 10.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. . Key factors driving the market include the introduction of novel and advanced products, a rise in investments in the biotechnology sector, and increasing demand for synthetic biology.
Increasing research and development expenditure for life sciences and biotechnology research is expected to drive the market significantly in the coming years. Over the past few decades, the biotechnology sector has witnessed a paradigm shift toward new treatments & drugs, biologically controlled production processes, genetically modified foods, biologically based computing, and new materials, thereby propelling the market growth.
Advancements in molecular diagnostic techniques, such as droplet digital PCR, NGS, and genome-wide sequencing with respect to accuracy, reproducibility, and timeline, have influenced the adoption of biotechnology reagents & kits in the market. The advent of long-read sequencing has made sequencing of longer strands of DNA possible by only reading single DNA molecules, in turn, driving the market growth.
Cell culture technology accounted for the largest revenue share in 2022 owing to the vast product portfolio offered by the key entities and expanding cell biology research. RNA-Seq using NGS technology has emerged as the method of choice for research communities investigating the transcriptome. The virus segment dominated the market in 2020 with increased adoption in cell & gene therapies and vaccinology. The ongoing pandemic has positively impacted the market growth as focused efforts are being conducted for vaccine development using viral vectors.
North America captured the maximum revenue share in 2022 with the U.S. being the largest contributor. The presence of key players coupled with active involvement in research activity has contributed to the maximum share of the region. Asia Pacific is projected to register the fastest CAGR from 2023 to 2030 owing to the improvements in health care infrastructure, entry of large biotechnological organizations, and increasing R&D activities. The key players in the global market are engaged in collaboration with biopharma developers to support their product development process.
Biotechnology Reagents & Kits Market Report Highlights:
The detection kits segment accounted for the maximum revenue share in 2022 owing to the high demand due to the pandemic
Amplification kits are anticipated to register a considerable growth rate due to the expanding applications of LAMP technology and PCR
The development of Point-of-Care (POC) testing has primarily driven the market for on-site testing
On-site DNA testing administers a broad array of DNA paternity and family relationship, including forensic DNA testing services and prenatal testing options
Currently, the healthcare segment is the key end-user of the market with the highest penetration of reagents & kits, in terms of usage, in this segment
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Kit type
1.1.2. Technology
1.1.3. Tested parameters
1.1.4. Micro-organisms
1.1.5. Purpose
1.1.6. End-use
1.1.7. Regional Scope
1.1.8. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Kit type outlook
2.2.2. Technology
2.2.3. Tested parameters
2.2.4. Micro-organisms
2.2.5. Purpose
2.2.6. End-use
2.2.7. Regional outlook
2.3. Competitive Insights
Chapter 3. Biotechnology Reagents & Kits Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Biotechnology Reagents & Kits Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Biotechnology Reagents & Kits: Kit Type Estimates & Trend Analysis
4.1. Biotechnology Reagents & Kits Market: Key Takeaways
4.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Purification Kits
4.3.1. Purification kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.4. Amplification Kits
4.4.1. Amplification kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.5. Detection Kits
4.5.1. Detection kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.6. Isolation Kits
4.6.1. Isolation kits market estimates and forecasts, 2018 to 2030 (USD Billion)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 5. Biotechnology Reagents & Kits: Technology Estimates & Trend Analysis
5.1. Biotechnology Reagents & Kits Market: Key Takeaways
5.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
5.3. LAMP technology
5.3.1. LAMP technology market estimates and forecasts, 2018 to 2030 (USD Billion)
5.4. PCR
5.4.1. PCR market estimates and forecasts, 2018 to 2030 (USD Billion)
5.5. Cell Structure
5.5.1. Cell structure market estimates and forecasts, 2018 to 2030 (USD Billion)
5.6. Sequencing
5.6.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Billion)
5.7. Chromatography
5.7.1. Chromatography market estimates and forecasts, 2018 to 2030 (USD Billion)
5.8. Electrophoresis
5.8.1. Electrophoresis market estimates and forecasts, 2018 to 2030 (USD Billion)
5.9. Flow Cytometry
5.9.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Billion)
5.10. Other technologies
5.10.1. Other technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 6. Biotechnology Reagents & Kits: Tested Parameter Estimates & Trend Analysis
6.1. Biotechnology Reagents & Kits Market: Key Takeaways
6.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
6.3. DNA
6.3.1. DNA market estimates and forecasts, 2018 to 2030 (USD Billion)
6.4. RNA
6.4.1. RNA market estimates and forecasts, 2018 to 2030 (USD Billion)
6.5. Enzymes
6.5.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Billion)
6.6. Proteins
6.6.1. Proteins market estimates and forecasts, 2018 to 2030 (USD Billion)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 7. Biotechnology Reagents & Kits: Micro-organisms Estimates & Trend Analysis
7.1. Biotechnology Reagents & Kits Market: Key Takeaways
7.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Bacteria
7.3.1. Bacteria market estimates and forecasts, 2018 to 2030 (USD Billion)
7.4. Virus
7.4.1. Virus market estimates and forecasts, 2018 to 2030 (USD Billion)
7.5. Fungi
7.5.1. Fungi market estimates and forecasts, 2018 to 2030 (USD Billion)
7.6. Parasites
7.6.1. Parasites market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 8. Biotechnology Reagents & Kits: Purpose Estimates & Trend Analysis
8.1. Biotechnology Reagents & Kits Market: Key Takeaways
8.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
8.3. On-site
8.3.1. On-site market estimates and forecasts, 2018 to 2030 (USD Billion)
8.4. Laboratory
8.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 9. Biotechnology Reagents & Kits: End-use Estimates & Trend Analysis
9.1. Biotechnology Reagents & Kits Market: Key Takeaways
9.2. Biotechnology Reagents & Kits Market: Movement & Market Share Analysis, 2022 & 2030
9.3. Healthcare
9.3.1. Healthcare market estimates and forecasts, 2018 to 2030 (USD Billion)
9.4. Food and Agriculture
9.4.1. Food and Agriculture market estimates and forecasts, 2018 to 2030 (USD Billion)
9.5. Natural Resources and Environment
9.5.1. Natural Resources and Environment market estimates and forecasts, 2018 to 2030 (USD Billion)
Chapter 10. Biotechnology Reagents & Kits Market: Regional Estimates & Trend Analysis
10.1. Regional Outlook
10.2. Biotechnology Reagents & Kits Market by Region: Key Takeaways
10.3. North America
10.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.3.2. U.S.
10.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.3.3. Canada
10.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4. Europe
10.4.1. UK
10.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.2. Germany
10.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.3. France
10.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.4. Italy
10.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.5. Spain
10.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.6. Denmark
10.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.7. Sweden
10.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.4.8. Norway
10.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5. Asia Pacific
10.5.1. Japan
10.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5.2. China
10.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5.3. India
10.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5.4. Australia
10.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5.5. Thailand
10.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.5.6. South Korea
10.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.6. Latin America
10.6.1. Brazil
10.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.6.2. Mexico
10.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.6.3. Argentina
10.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.7. MEA
10.7.1. South Africa
10.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.7.2. Saudi Arabia
10.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.7.3. UAE
10.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
10.7.4. Kuwait
10.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 11. Competitive Landscape
11.1. Recent Developments & Impact Analysis, By Key Market Participants
11.2. Market Participant Categorization
11.2.1. Thermos Fisher Scientific
11.2.1.1. Company overview
11.2.1.2. Financial performance
11.2.1.3. Product benchmarking
11.2.1.4. Strategic initiatives
11.2.2. QIAGEN
11.2.2.1. Company overview
11.2.2.2. Financial performance
11.2.2.3. Product benchmarking
11.2.2.4. Strategic initiatives
11.2.3. New England Biolabs
11.2.3.1. Company overview
11.2.3.2. Financial performance
11.2.3.3. Product benchmarking
11.2.3.4. Strategic initiatives
11.2.4. Illumina, Inc.
11.2.4.1. Company overview
11.2.4.2. Financial performance
11.2.4.3. Product benchmarking
11.2.4.4. Strategic initiatives
11.2.5. Agilent Technologies, Inc.
11.2.5.1. Company overview
11.2.5.2. Financial performance
11.2.5.3. Product benchmarking
11.2.5.4. Strategic initiatives
11.2.6. Bio Rad Laboratories
11.2.6.1. Company overview
11.2.6.2. Financial performance
11.2.6.3. Product benchmarking
11.2.6.4. Strategic initiatives
11.2.7. F. Hoffman-La Roche Ltd.
11.2.7.1. Company overview
11.2.7.2. Financial performance
11.2.7.3. Product benchmarking
11.2.7.4. Strategic initiatives
11.2.8. Merck KGaA
11.2.8.1. Company overview
11.2.8.2. Financial performance
11.2.8.3. Product benchmarking
11.2.8.4. Strategic initiatives
11.2.9. Promega Corp.
11.2.9.1. Company overview
11.2.9.2. Financial performance
11.2.9.3. Product benchmarking
11.2.9.4. Strategic initiatives
11.2.10. Takara Bio, Inc.
11.2.10.1. Company overview
11.2.10.2. Financial performance
11.2.10.3. Product benchmarking
11.2.10.4. Strategic initiatives
11.2.11. LGC Ltd.
11.2.11.1. Company overview
11.2.11.2. Financial performance
11.2.11.3. Product benchmarking
11.2.11.4. Strategic initiatives
11.2.12. Toyobo Co. Ltd
11.2.12.1. Company overview
11.2.12.2. Financial performance
11.2.12.3. Product benchmarking
11.2.12.4. Strategic initiatives
°ü·ÃÀÚ·á